Craig E. Metroka

4.9k total citations · 1 hit paper
22 papers, 2.9k citations indexed

About

Craig E. Metroka is a scholar working on Oncology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Craig E. Metroka has authored 22 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 6 papers in Epidemiology. Recurrent topics in Craig E. Metroka's work include Viral-associated cancers and disorders (13 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Craig E. Metroka is often cited by papers focused on Viral-associated cancers and disorders (13 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Craig E. Metroka collaborates with scholars based in United States, Canada and Russia. Craig E. Metroka's co-authors include Warren M. Gold, William D. Snider, Jerome B. Posner, David M. Simpson, Surl L. Nielsen, Susan E. Krown, J Wernz, George Miller, James C. Wernz and Elizabeth Grogan and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Craig E. Metroka

21 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients

1983 1.0k citations William D. Snider, David M. Simpson et al. Annals of Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Craig E. Metroka United States	17	1.5k	1.3k	808	789	566	22	2.9k
Cecilia Simonelli Italy	24	770 0.5×	517 0.4×	372 0.5×	372 0.5×	452 0.8×	78	3.2k
Dharam V. Ablashi United States	41	3.3k 2.1×	4.6k 3.6×	1.7k 2.2×	384 0.5×	515 0.9×	142	6.4k
Robert Y. Foos United States	36	256 0.2×	1.5k 1.2×	489 0.6×	408 0.5×	159 0.3×	111	4.6k
Guislaine Carcelain France	38	945 0.6×	1.9k 1.5×	2.5k 3.1×	2.8k 3.5×	244 0.4×	91	5.3k
Sheila C. Dollard United States	35	1.2k 0.8×	4.5k 3.6×	2.3k 2.8×	314 0.4×	165 0.3×	87	5.6k
Silvia Sánchez‐Ramón Spain	32	384 0.2×	395 0.3×	412 0.5×	240 0.3×	391 0.7×	171	3.2k
Eduardo Fernández‐Cruz Spain	30	261 0.2×	557 0.4×	417 0.5×	482 0.6×	218 0.4×	121	2.5k
Maria Luisa Villa Italy	28	329 0.2×	700 0.6×	587 0.7×	841 1.1×	138 0.2×	73	3.2k
James C. Niederman United States	24	1.9k 1.2×	1.2k 0.9×	1.4k 1.7×	54 0.1×	577 1.0×	45	2.8k
R Biagiotti Italy	24	455 0.3×	570 0.4×	380 0.5×	239 0.3×	288 0.5×	65	4.1k

Countries citing papers authored by Craig E. Metroka

Since Specialization

Citations

This map shows the geographic impact of Craig E. Metroka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig E. Metroka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig E. Metroka more than expected).

Fields of papers citing papers by Craig E. Metroka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig E. Metroka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig E. Metroka. The network helps show where Craig E. Metroka may publish in the future.

Co-authorship network of co-authors of Craig E. Metroka

This figure shows the co-authorship network connecting the top 25 collaborators of Craig E. Metroka. A scholar is included among the top collaborators of Craig E. Metroka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig E. Metroka. Craig E. Metroka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Metroka, Craig E., et al.. (2007). Treatment of HIV-associated dyslipidemia: a role for omega-3 fatty acids.. PubMed. 17(7). 362–4, 367. 10 indexed citations

Gradoville, Lyndle, J Gerlach, Elizabeth Grogan, et al.. (2000). Kaposi's Sarcoma-Associated Herpesvirus Open Reading Frame 50/Rta Protein Activates the Entire Viral Lytic Cycle in the HH-B2 Primary Effusion Lymphoma Cell Line. Journal of Virology. 74(13). 6207–6212. 240 indexed citations

Staskus, Katherine, Ren Sun, George Miller, et al.. (1999). Cellular Tropism and Viral Interleukin-6 Expression Distinguish Human Herpesvirus 8 Involvement in Kaposi’s Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman’s Disease. Journal of Virology. 73(5). 4181–4187. 202 indexed citations

Zong, Jian, Craig E. Metroka, M S Reitz, John Nicholas, & Gary S. Hayward. (1997). Strain variability among Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genomes: evidence that a large cohort of United States AIDS patients may have been infected by a single common isolate. Journal of Virology. 71(3). 2505–2511. 97 indexed citations

Miller, George, Michael O. Rigsby, Lee Heston, et al.. (1996). Antibodies to Butyrate-Inducible Antigens of Kaposi's Sarcoma–Associated Herpesvirus in Patients with HIV-1 Infection. New England Journal of Medicine. 334(20). 1292–1297. 208 indexed citations

Kahn, James O., W P Tong, Michael Feldstein, et al.. (1995). Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group.. PubMed. 9(2). 138–44. 23 indexed citations

Nisce, Lourdes Z., Thomas Kaufmann, & Craig E. Metroka. (1992). . JAMA. 267(14). 1921–1922. 4 indexed citations

Ames, Elizabeth D., et al.. (1991). Hodgkin's Disease and AIDS. Hematology/Oncology Clinics of North America. 5(2). 343–356. 54 indexed citations

Krown, Susan E., Craig E. Metroka, & J Wernz. (1989). Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee.. Journal of Clinical Oncology. 7(9). 1201–1207. 339 indexed citations

10.

Chadburn, Amy, Craig E. Metroka, & Janet Mouradian. (1989). Progressive lymph node histology and its prognostic value in patients with acquired immunodeficiency syndrome and AIDS-related complex. Human Pathology. 20(6). 579–587. 46 indexed citations

11.

Krown, Susan E., Craig E. Metroka, & James C. Wernz. (1989). Kaposi's Sarcoma in the Acquired Immune Deficiency Syndrome: A Proposal for Uniform Evaluation, Response, and Staging Criteria. 173 indexed citations

12.

Lowe, Franklin C., et al.. (1989). Kaposi’s Sarcoma of the Penis in Patients with Acquired Immunodeficiency Syndrome. The Journal of Urology. 142(6). 1475–1477. 37 indexed citations

13.

Grieco, Michael H., Michael Lange, Elena Buimovici‐Klein, et al.. (1988). Open study of AL-721 treatment of HIV-infected subjects with generalized lymphadenopathy syndrome: An eight week open trial and follow-up. Antiviral Research. 9(3). 177–190. 6 indexed citations

14.

Cunningham‐Rundles, S., Craig E. Metroka, Bijan Safai, et al.. (1985). Cytotoxic Effector Mechanisms in AIDS. Advances in experimental medicine and biology. 187. 97–110. 1 indexed citations

15.

Pollack, Marilyn S., Jonathan Gold, Craig E. Metroka, Bijan Safai, & Bo Dupont. (1984). HLA-A,B,C and DR antigen frequencies in acquired immunodeficiency syndrome (AIDS) patients with opportunistic infections. Human Immunology. 11(2). 99–103. 26 indexed citations

16.

Metroka, Craig E., Susanna Cunningham–Rundles, Mathilde Krim, et al.. (1984). GENERALIZED LYMPHADENOPATHY IN HOMOSEXUAL MEN: AN UPDATE OF THE NEW YORK EXPERIENCE. Annals of the New York Academy of Sciences. 437(1). 400–411. 3 indexed citations

17.

Tatsumi, E, Shinji Harada, Joanne Yetz, et al.. (1983). EPSTEIN-BARR VIRUS AND CHRONIC LYMPHADENOMEGALY IN MALE HOMOSEXUALS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS). PubMed. 1(1). 59–82. 21 indexed citations

18.

Snider, William D., David M. Simpson, Surl L. Nielsen, et al.. (1983). Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients. Annals of Neurology. 14(4). 403–418. 1049 indexed citations breakdown →

19.

Hanafusa, Terukiyo, Hidesaburô Hanafusa, Craig E. Metroka, et al.. (1976). Pheasant virus: new class of ribodeoxyvirus.. Proceedings of the National Academy of Sciences. 73(4). 1333–1337. 31 indexed citations

20.

Kawai, Sadaaki, Craig E. Metroka, & Hidesaburô Hanafusa. (1972). Complementation of functions required for cell transformation by double infection with RSV mutants. Virology. 49(1). 302–304. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact